UCB receives positive CHMP opinion for CIMZIA® (certolizumab pegol) dose ...
(WorldNews Belgium)

UCB will bring first electronic injection device to rheumatology patients in EU Brussels, Belgium - April 26, 2017 - UCB has announced that the European Medicines Agency`s (EMA`s) Committee for Medicinal Products for Human Use (CHMP) has recommended the CIMZIA dose dispenser cartridge for use with the re-usable ava electronic injection device in all approved indications. `UCB recognizes the unique and varying needs of people living with immunologic diseases. With our extensive, uniquely tailored portfolio of devices designed in partnership with patients, physicians, and payers, patients now have multiple administration options. Our innovative new e-device, ava, gives patients a choice that...